GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc. resulted from the business combination of Capstar Special Purpose Acquisition Corp (Nasdaq: CPSR), sponsored by Capstar SPAC Management LLC, and Gelesis S.r.l., a commercial-stage biotherapeutics company focused on hydrogel-based treatments for weight management and metabolic health, including its flagship product Plenity. Capstar completed its IPO in 2021 targeting the healthcare sector, and the transaction was formalized via an 8-K filing dated January 12, 2022, marking the close of the de-SPAC process. Following completion, the combined company began trading on the NYSE under the ticker GLS. Sign up on SpacDesk for the full data profile on Gelesis Holdings and hundreds of other SPAC transactions.